Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1

Journal of Leukocyte Biology

Volumn 99, Issue 2, 2016, Pages 333-347

  Pelekanou, Vasiliki ^a,e   Kampa, Marilena ^a   Kiagiadaki, Foteini ^a   Deli, Alexandra ^a   Theodoropoulos, Panayiotis ^a   Agrogiannis, George ^b   Patsouris, Efstratios ^b   Tsapis, Andreas ^a,c,d   Castanas, Elias ^a   Notas, George ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; IL 6; Macrophages; NF kB

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA 36; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; G PROTEIN ESTROGEN RECEPTOR 1; INTERLEUKIN 6; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA, HUMAN; FULVESTRANT; GPER PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; ISOPROTEIN; LIPOPOLYSACCHARIDE; RELA PROTEIN, HUMAN; SMALL INTERFERING RNA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG MECHANISM; ESTROGEN ACTIVITY; FEMALE; FOAM CELL; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOLECULAR WEIGHT; MONOCYTE; PRIORITY JOURNAL; SPLICING DEFECT; AGED; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; CHEMISTRY; CORONARY ARTERY DISEASE; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; MYELOPOIESIS; PATHOLOGY; PHYSIOLOGY; PROTEIN ANALYSIS; REPORTER GENE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AGED; ANTI-INFLAMMATORY AGENTS; CELL LINE, TUMOR; CELL NUCLEUS; CORONARY ARTERY DISEASE; DENDRITIC CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; FOAM CELLS; GENES, REPORTER; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; MYELOPOIESIS; PROTEIN INTERACTION MAPPING; PROTEIN ISOFORMS; RECEPTOR CROSS-TALK; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84957612468     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A0914-430RR     Document Type: Article

References (85)

1. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
2. Rossol, M., Heine, H., Meusch, U., Quandt, D., Klein, C., Sweet, M. J., Hauschildt, S. (2011) LPS-induced cytokine production in human monocytes and macrophages. Crit. Rev. Immunol. 31, 379-446.
3. Ishihara, K., Hirano, T. (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13, 357-368.
4. Kishimoto, T. (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res. Ther. 8(Suppl 2), S2.
5. Rattazzi, M., Puato, M., Faggin, E., Bertipaglia, B., Zambon, A., Pauletto, P. (2003) C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J. Hypertens. 21, 1787-1803.
6. Hansson, G. K., Robertson, A. K., Söderberg-Nauclér, C. (2006) Inflammation and atherosclerosis. Annu. Rev. Pathol. 1, 297-329.
7. Hansson, G. K. (2005) Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695.
8. Campbell, L. A., Rosenfeld, M. E. (2015) Infection and atherosclerosis development. Arch. Med. Res. 46, 339-350.
9. Hsieh, Y. C., Frink, M., Hsieh, C. H., Choudhry, M. A., Schwacha, M. G., Bland, K. I., Chaudry, I. H. (2007) Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L1227-L1232.
10. Messingham, K. A., Heinrich, S. A., Kovacs, E. J. (2001) Estrogen restores cellular immunity in injured male mice via suppression of interleukin-6 production. J. Leukoc. Biol. 70, 887-895.
11. Pioli, P. A., Jensen, A. L., Weaver, L. K., Amiel, E., Shen, Z., Shen, L., Wira, C. R., Guyre, P. M. (2007) Estradiol attenuates lipopolysaccharideinduced CXC chemokine ligand 8 production by human peripheral blood monocytes. J. Immunol. 179, 6284-6290.
12. Suzuki, T., Yu, H. P., Hsieh, Y. C., Choudhry, M. A., Bland, K. I., Chaudry, I. H. (2008) Estrogen-mediated activation of non-genomic pathway improves macrophages cytokine production following traumahemorrhage. J. Cell. Physiol. 214, 662-672.
13. Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., Manolagas, S. C. (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257, 88-91.
14. Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C., Manolagas, S. C. (1992) 17 Beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89, 883-891.
15. Lin, S. C., Yamate, T., Taguchi, Y., Borba, V. Z., Girasole, G., O'Brien, C. A., Bellido, T., Abe, E., Manolagas, S. C. (1997) Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J. Clin. Invest. 100, 1980-1990.
16. Mendelsohn, M. E., Karas, R. H. (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308, 1583-1587.
17. Jansson, L., Olsson, T., Holmdahl, R. (1994) Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J. Neuroimmunol. 53, 203-207.
18. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J. M., Argos, P., Chambon, P. (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320, 134-139.
19. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., Gustafsson, J. A. (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93, 5925-5930.
20. Kampa, M., Pelekanou, V., Notas, G., Stathopoulos, E. N., Castanas, E. (2013) The estrogen receptor: two or more molecules, multiple variants, diverse localizations, signaling and functions. Are we undergoing a paradigm-shift as regards their significance in breast cancer? Hormones (Athens) 12, 69-85.
21. Levin, E. R. (2009) G protein-coupled receptor 30: estrogen receptor or collaborator? Endocrinology 150, 1563-1565.
22. Thomas, P., Pang, Y., Filardo, E. J., Dong, J. (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146, 624-632.
23. Wang, Z., Zhang, X., Shen, P., Loggie, B. W., Chang, Y., Deuel, T. F. (2005) Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem. Biophys. Res. Commun. 336, 1023-1027.
24. Wang, Z., Zhang, X., Shen, P., Loggie, B. W., Chang, Y., Deuel, T. F. (2006) A variant of estrogen receptor-alpha, hER-alpha36: transduction of estrogen-and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Natl. Acad. Sci. USA 103, 9063-9068.
25. Komi, J., Lassila, O. (2000) Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood 95, 2875-2882.
26. Murphy, A. J., Guyre, P. M., Wira, C. R., Pioli, P. A. (2009) Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. PLoS One 4, e5539.
27. Mao, A., Paharkova-Vatchkova, V., Hardy, J., Miller, M. M., Kovats, S. (2005) Estrogen selectively promotes the differentiation of dendritic cells with characteristics of Langerhans cells. J. Immunol. 175, 5146-5151.
28. Dennis, M. K., Burai, R., Ramesh, C., Petrie, W. K., Alcon, S. N., Nayak, T. K., Bologa, C. G., Leitao, A., Brailoiu, E., Deliu, E., Dun, N. J., Sklar, L. A., Hathaway, H. J., Arterburn, J. B., Oprea, T. I., Prossnitz, E. R. (2009) In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 5, 421-427.
29. Robertson, D., Savage, K., Reis-Filho, J. S., Isacke, C. M. (2008) Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue. BMC Cell Biol. 9, 13.
30. Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., Tinevez, J. Y., White, D. J., Hartenstein, V., Eliceiri, K., Tomancak, P., Cardona, A. (2012) Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676-682.
31. Pelekanou, V., Notas, G., Theodoropoulou, K., Kampa, M., Takos, D., Alexaki, V. I., Radojicic, J., Sofras, F., Tsapis, A., Stathopoulos, E. N., Castanas, E. (2011) Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas. Anal. Cell Pathol. (Amst.) 34, 49-60.
32. Notas, G., Nifli, A. P., Kampa, M., Pelekanou, V., Alexaki, V. I., Theodoropoulos, P., Vercauteren, J., Castanas, E. (2012) Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells. J. Nutr. Biochem. 23, 656-666.
33. Notas, G., Kampa, M., Pelekanou, V., Castanas, E. (2012) Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: a pharmacological approach. Steroids 77, 943-950.
34. Suzuki, H., Katayama, N., Ikuta, Y., Mukai, K., Fujieda, A., Mitani, H., Araki, H., Miyashita, H., Hoshino, N., Nishikawa, H., Nishii, K., Minami, N., Shiku, H. (2004) Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes. Am. J. Hematol. 75, 179-189.
35. Polancec, D. S., Munic Kos, V., Banjanac, M., Vrancic, M., Cuzic, S., Belamaric, D., Parnham, M. J., Polancec, D., Erakovic Haber, V. (2012) Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties. J. Leukoc. Biol. 91, 229-243.
36. Taylor, C. R. (1996) Paraffin section immunocytochemistry for estrogen receptor: the time has come. Cancer 77, 2419-2422.
37. Pertschuk, L. P., Feldman, J. G., Kim, Y. D., Braithwaite, L., Schneider, F., Braverman, A. S., Axiotis, C. (1996) Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays. Cancer 77, 2514-2519.
38. Pelekanou, V., Notas, G., Kampa, M., Tsentelierou, E., Radojicic, J., Leclercq, G., Castanas, E., Stathopoulos, E. N. (2012) ERa36, a new variant of the ERa is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines. Steroids 77, 928-934.
39. Hsiao, J. J., Ng, B. H., Smits, M. M., Wang, J., Jasavala, R. J., Martinez, H. D., Lee, J., Alston, J. J., Misonou, H., Trimmer, J. S., Wright, M. E. (2015) Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility. BMC Cancer 15, 204.
40. Morán-Auth, Y., Penna-Martinez, M., Shoghi, F., Ramos-Lopez, E., Badenhoop, K. (2013) Vitamin D status and gene transcription in immune cells. J. Steroid Biochem. Mol. Biol. 136, 83-85.
41. Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., Tada, K. (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26, 171-176.
42. Kramer, P. R., Kramer, S. F., Guan, G. (2004) 17 Beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum. 50, 1967-1975.
43. Qin, Z. (2012) The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 221, 2-11.
44. Mor, G., Sapi, E., Abrahams, V. M., Rutherford, T., Song, J., Hao, X. Y., Muzaffar, S., Kohen, F. (2003) Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J. Immunol. 170, 114-122.
45. Sherman, B. M., Korenman, S. G. (1975) Hormonal characteristics of the human menstrual cycle throughout reproductive life. J. Clin. Invest. 55, 699-706.
46. Howell, A., Osborne, C. K., Morris, C., Wakeling, A. E. (2000) ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer 89, 817-825.
47. Chevalier, N., Vega, A., Bouskine, A., Siddeek, B., Michiels, J. F., Chevallier, D., Fénichel, P. (2012) GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation. PLoS One 7, e34672.
48. Lee, E., Sidoryk-Wêgrzynowicz, M., Wang, N., Webb, A., Son, D. S., Lee, K., Aschner, M. (2012) GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes. J. Biol. Chem. 287, 26817-26828.
49. Fang, H., Pengal, R. A., Cao, X., Ganesan, L. P., Wewers, M. D., Marsh, C. B., Tridandapani, S. (2004) Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J. Immunol. 173, 360-366.
50. Cerillo, G., Rees, A., Manchanda, N., Reilly, C., Brogan, I., White, A., Needham, M. (1998) The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner. J. Steroid Biochem. Mol. Biol. 67, 79-88.
51. McMurray, R. W., Ndebele, K., Hardy, K. J., Jenkins, J. K. (2001) 17-Betaestradiol suppresses IL-2 and IL-2 receptor. Cytokine 14, 324-333.
52. Stice, J. P., Knowlton, A. A. (2008) Estrogen, NFkappaB, and the heat shock response. Mol. Med. 14, 517-527.
53. Liu, C. J., Lo, J. F., Kuo, C. H., Chu, C. H., Chen, L. M., Tsai, F. J., Tsai, C. H., Tzang, B. S., Kuo, W. W., Huang, C. Y. (2009) Akt mediates 17betaestradiol and/or estrogen receptor-alpha inhibition of LPS-induced tumor necrosis factor-alpha expression and myocardial cell apoptosis by suppressing the JNK1/2-NFkappaB pathway. J. Cell. Mol. Med. 13, 3655-3667.
54. Giraud, S. N., Caron, C. M., Pham-Dinh, D., Kitabgi, P., Nicot, A. B. (2010) Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. Proc. Natl. Acad. Sci. USA 107, 8416-8421.
55. Xing, D., Oparil, S., Yu, H., Gong, K., Feng, W., Black, J., Chen, Y. F., Nozell, S. (2012) Estrogen modulates NFkB signaling by enhancing IkBa levels and blocking p65 binding at the promoters of inflammatory genes via estrogen receptor-b. PLoS One 7, e36890.
56. Kerdivel, G., Boudot, A., Pakdel, F. (2013) Estrogen represses CXCR7 gene expression by inhibiting the recruitment of NFkB transcription factor at the CXCR7 promoter in breast cancer cells. Biochem. Biophys. Res. Commun. 431, 729-733.
57. Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M. P., Bours, V., Franchimont, N. (2006) Raloxifene-induced myeloma cell apoptosis: a study of nuclear factorkappaB inhibition and gene expression signature. Mol. Pharmacol. 69, 1615-1623.
58. Stein, B., Yang, M. X. (1995) Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell. Biol. 15, 4971-4979.
59. Nettles, K. W., Gil, G., Nowak, J., Métivier, R., Sharma, V. B., Greene, G. L. (2008) CBP Is a dosage-dependent regulator of nuclear factorkappaB suppression by the estrogen receptor. Mol. Endocrinol. 22, 263-272.
60. Akoumianaki, T., Kardassis, D., Polioudaki, H., Georgatos, S. D., Theodoropoulos, P. A. (2009) Nucleocytoplasmic shuttling of soluble tubulin in mammalian cells. J. Cell Sci. 122, 1111-1118.
61. Lombardi, M., Castoria, G., Migliaccio, A., Barone, M. V., Di Stasio, R., Ciociola, A., Bottero, D., Yamaguchi, H., Appella, E., Auricchio, F. (2008) Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells. J. Cell Biol. 182, 327-340.
62. Nonclercq, D., Journé, F., Laïos, I., Chaboteaux, C., Toillon, R. A., Leclercq, G., Laurent, G. (2007) Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells. J. Mol. Endocrinol. 39, 105-118.
63. Shashkin, P., Dragulev, B., Ley, K. (2005) Macrophage differentiation to foam cells. Curr. Pharm. Des. 11, 3061-3072.
64. Matejuk, A., Adlard, K., Zamora, A., Silverman, M., Vandenbark, A. A., Offner, H. (2001) 17 Beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J. Neurosci. Res. 65, 529-542.
65. De Bosscher, K., Vanden Berghe, W., Haegeman, G. (2006) Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 25, 6868-6886.
66. Zou, P., Qu, C., Xu, Y., Li, H., Han, D., Shi, D., Zou, W. (2013) Estrogen receptor alpha 36 gene knockdown promote the expression of NF-kB in PC12 cells. Open J. Endocr. Metab. Dis. 3, 20-24.
67. Prossnitz, E. R., Barton, M. (2011) The G-protein-coupled estrogen receptor GPER in health and disease. Nat. Rev. Endocrinol. 7, 715-726.
68. Prossnitz, E. R., Arterburn, J. B. (2015) International Union of Basic and Clinical Pharmacology. XCVII. G protein-coupled estrogen receptor and its pharmacologic modulators. Pharmacol. Rev. 67, 505-540.
69. Dennis, M. K., Field, A. S., Burai, R., Ramesh, C., Petrie, W. K., Bologa, C. G., Oprea, T. I., Yamaguchi, Y., Hayashi, S., Sklar, L. A., Hathaway, H. J., Arterburn, J. B., Prossnitz, E. R. (2011) Identification of a GPER/ GPR30 antagonist with improved estrogen receptor counterselectivity. J. Steroid Biochem. Mol. Biol. 127, 358-366.
70. Kang, L., Zhang, X., Xie, Y., Tu, Y., Wang, D., Liu, Z., Wang, Z. Y. (2010) Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol. 24, 709-721.
71. Ren, J.,Wu, J. H. (2012) 17b-Estradiol rapidly activates calcium release from intracellular stores via the GPR30 pathway and MAPK phosphorylation in osteocyte-like MLO-Y4 cells. Calcif. Tissue Int. 90, 411-419.
72. Patkar, S., Farr, T. D., Cooper, E., Dowell, F. J., Carswell, H. V. (2011) Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery. Neurosci. Res. 71, 78-84.
73. Teng, Y., Radde, B. N., Litchfield, L. M., Ivanova, M. M., Prough, R. A., Clark, B. J., Doll, M. A., Hein, D. W., Klinge, C. M. (2015) Dehydroepiandrosterone activation of G-protein-coupled estrogen receptor rapidly stimulates microRNA-21 transcription in human hepatocellular carcinoma cells. J. Biol. Chem. 290, 15799-15811.
74. Notas, G., Kampa, M., Pelekanou, V., Troullinaki, M., Jacquot, Y., Leclercq, G., Castanas, E. (2013) Whole transcriptome analysis of the ERa synthetic fragment P295-T311 (ERa17p) identifies specific ERaisoform (ERa, ERa36)-dependent and-independent actions in breast cancer cells. Mol. Oncol. 7, 595-610.
75. Ylikomi, T., Bocquel, M. T., Berry, M., Gronemeyer, H., Chambon, P. (1992) Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J. 11, 3681-3694.
76. Robbins, C. S., Hilgendorf, I., Weber, G. F., Theurl, I., Iwamoto, Y., Figueiredo, J. L., Gorbatov, R., Sukhova, G. K., Gerhardt, L. M., Smyth, D., Zavitz, C. C., Shikatani, E. A., Parsons, M., van Rooijen, N., Lin, H. Y., Husain, M., Libby, P., Nahrendorf, M., Weissleder, R., Swirski, F. K. (2013) Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19, 1166-1172.
77. Seneviratne, A. N., Sivagurunathan, B., Monaco, C. (2012) Toll-like receptors and macrophage activation in atherosclerosis. Clin. Chim. Acta 413, 3-14.
78. Kristiansen, O. P., Mandrup-Poulsen, T. (2005) Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54(Suppl 2), S114-S124.
79. Wang, D., Liu, Z., Li, Q., Karpurapu, M., Kundumani-Sridharan, V., Cao, H., Dronadula, N., Rizvi, F., Bajpai, A. K., Zhang, C., Müller-Newen, G., Harris, K. W., Rao, G. N. (2007) An essential role for GP130 in neointima formation following arterial injury. Circ. Res. 100, 807-816.
80. Wang, Z., Castresana, M. R., Newman, W. H. (2001) NF-kappaB is required for TNF-alpha-directed smooth muscle cell migration. FEBS Lett. 508, 360-364.
81. Wang, Z., Castresana, M. R., Newman, W. H. (2001) Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 285, 669-674.
82. Liu, C. J., Kuo, F. C., Hu, H. M., Chen, C. Y., Huang, Y. B., Cheng, K. H., Yokoyama, K. K., Wu, D. C., Hsieh, S., Kuo, C. H. (2014) 17b-Estradiol inhibition of IL-6-Src and Cas and paxillin pathway suppresses human mesenchymal stem cells-mediated gastric cancer cell motility. Transl. Res. 164, 232-243.
83. Meyer, M. R., Fredette, N. C., Howard, T. A., Hu, C., Ramesh, C., Daniel, C., Amann, K., Arterburn, J. B., Barton, M., Prossnitz, E. R. (2014) G protein-coupled estrogen receptor protects from atherosclerosis. Sci. Rep. 4, 7564.
84. Cabas, I., Rodenas, M. C., Abellán, E., Meseguer, J., Mulero, V., García-Ayala, A. (2013) Estrogen signaling through the G protein-coupled estrogen receptor regulates granulocyte activation in fish. J. Immunol. 191, 4628-4639.
85. Rettew, J. A., McCall IV, S. H., Marriott, I. (2010) GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages. Mol. Cell. Endocrinol. 328, 87-92.